CD22 Test

The CD22 test is a blood test that measures the level of CD22 protein in the blood. CD22 is a protein that is found on the surface of B cells, a type of white blood cell. The test is used to diagnose and monitor B cell lymphoma and hairy cell leukaemia.

The CD22 test is a simple and painless procedure. A blood sample is drawn from a vein in the arm. The sample is then sent to a laboratory for analysis. The results of the test are usually available within 2–3 days.

Normal Range

The normal range for CD22 levels in the blood varies depending on age and sex. In general, the normal range for adults is 100-500 ng/mL.

Abnormal Results

An elevated level of CD22 in the blood may indicate a B cell lymphoma or hairy cell leukaemia. However, an elevated level of CD22 can also be caused by other conditions, such as infection, inflammation, or autoimmune disorders.

Interpreting the Results

The results of the CD22 test should be interpreted by a doctor. The doctor will consider the patient's symptoms, medical history, and other test results when interpreting the results.

Preparation for the Test

There is no special preparation required for the CD22 test. However, the patient should tell the doctor if they are taking any medications that can affect the results of the test.

Risks of the Test

There are no known risks associated with the CD22 test. However, as with any blood test, there is a small risk of bleeding, bruising, or infection at the injection site.

Cost of the Test

The cost of the CD22 test varies depending on the location of the test and the laboratory that performs the test. In India, the cost of the CD22 test is at healthcare nt sickcare is ₹2999.

Conclusion

The CD22 test is a useful tool for diagnosing and monitoring B cell lymphoma and hairy cell leukaemia. The test is a simple and painless procedure with no known risks. If you have any questions about the CD22 test, please talk to your doctor.